Navigation Links
Significant dementia risk attributable to small blood vessel damage
Date:4/6/2008

Autopsy data of 221 men and women found that the brains of one-third of individuals who had dementia before death showed evidence of small, cumulative blood vessel damage that can arise from hypertension or diabetes.

Dr. Thomas Montine and colleagues analyzed the brain tissue of select volunteers from the Adult Changes in Thought (ACT) study, wherein 3,400 adult participants (65+) in the Seattle region agreed to undergo neurological and psychological tests every two years until their death

While some results were unsurprising, such as showing that changes due to Alzheimers disease or the formation of Lewy bodies (structures indicative of a degenerative disease known as Lewy Body Dementia) accounted for significant dementia risk, the researchers also found that about 33% of dementia risk was associated with brain damage from small vessel disease. This small vessel damage is the cumulative effect of multiple tiny strokes caused by hypertension and diabetes, strokes so small that the person experiences no sensation or problems until they reach a tipping point.

While unexpected, this finding may be good news, because while Alzheimers treatments remain investigational, there are many options to reduce hypertension and diabetes.


'/>"/>

Contact: Sarah Goodwin
ebpress@gmail.com
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1

Related medicine news :

1. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
2. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
3. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
4. Study shows adverse drug events reported to the FDA have significantly increased
5. Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs
6. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
7. Rehabilitation significantly underused after heart attack and bypass surgery
8. First significant genetic finding in severe PMS, or PMDD
9. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
10. National Domestic Violence Hotline Unveils 10-Year Blueprint to Significantly Reduce Domestic Violence in America
11. New Study Shows Arthritis Significantly Limits Millions of Americans Ability to Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Miami, FL (PRWEB) , ... May 26, 2016 , ... ... day of events featuring guest speaker Dr. Adonis Maiquez MD, ABAARM. Dr. Adonis ... Anti-Aging and Regenerative Medicine, and a member of the Institute for Functional Medicine. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the ... bunionette) treatment was more than humbled by customer demand over the Mother’s Day Weekend ... mid sale. Now that Bunion Bootie has completely replenished its inventory levels, it hopes ...
(Date:5/26/2016)... Redwood City, CA (PRWEB) , ... May 26, 2016 , ... ... time, Silicon Valley-based startup, The Dough Bar, has ignited an undeniable buzz ... shake -- a doughnut. But not just any doughnut.  These doughnuts are packed with ...
(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & Associates’ ... 20 years of experience in leading technology and human resources operations for health ... teaching, Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , Innovative ...
(Date:5/26/2016)... ... , ... Dr. LeRoy Perry’s recently authored whitepaper, “Tech Neck and ROI (return ... of users, hundreds of millions of whom are coming into the workplace with pain ... common action of looking down at hand-held technology devices (tablets, smartphones) for extended periods ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland , ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... agreement with Therawis Diagnostics GmbH to develop and commercialize predictive ... and market PITX2 as a marker to predict effectiveness of ... patients. "We are pleased to partner with Therawis, ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
Breaking Medicine Technology: